A multicenter phase II study of adjuvant chemotherapy with oral fluoropyrimidine S-1 for non-small-cell lung cancer: high completion and survival rates. [electronic resource]
Producer: 20130308Description: 464-9 p. digitalISSN:- 1938-0690
- Administration, Oral
- Aged
- Ambulatory Care -- methods
- Antimetabolites, Antineoplastic -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Chemotherapy, Adjuvant -- methods
- Combined Modality Therapy
- Dose-Response Relationship, Drug
- Drug Combinations
- Feasibility Studies
- Female
- Follow-Up Studies
- Humans
- Incidence
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Recurrence, Local
- Oxonic Acid -- administration & dosage
- Tegafur -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.